glp 1 drugs and breast cancer GLP-1 use linked to lower incidence Glucagon-like peptide 1 receptor agonists

Yuan, W

These findings are important as they may broaden the indications for these medications and benefit a larger patient population, added Mir Ali, MD, a general surgeon and bariatric surgeon as well as the medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA

Phase III, PIONEER Program Multiple phase III efficacy trials have been fully published and/or presented in abstract form

In: Office of disease prevention and health promotion USDoHaHS, ed

This information will help reduce the risk of any drug interactions or adverse reactions

In patients with obesity, with or without diabetes, significant weight loss (and improvement in weight-related complications) has been consistently demonstrated 8,9,10